82 FR 52301 - Proposed Data Collection Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 217 (November 13, 2017)

Page Range52301-52302
FR Document2017-24523

The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed work and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the Evaluation of the Cancer Survivorship Demonstration Project. This information collection aims to help CDC better understand strategies and best practices to identify and address current cancer survivorship needs and gaps.

Federal Register, Volume 82 Issue 217 (Monday, November 13, 2017)
[Federal Register Volume 82, Number 217 (Monday, November 13, 2017)]
[Notices]
[Pages 52301-52302]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-24523]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-18-18AG; Docket No. CDC-2017-0095]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed work 
and/or continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on the Evaluation of 
the Cancer Survivorship Demonstration Project. This information 
collection aims to help CDC better understand strategies and best 
practices to identify and address current cancer survivorship needs and 
gaps.

DATES: CDC must receive written comments on or before January 12, 2018.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0095 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Leroy A. Richardson, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE., MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-
3520), Federal agencies must obtain approval from the Office of 
Management and Budget (OMB) for each collection of information they 
conduct or sponsor. In addition, the PRA also requires Federal agencies 
to provide a 60-day notice in the Federal Register concerning each 
proposed collection of information, including each new proposed 
collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Evaluation of the Cancer Survivorship Demonstration Project--New--
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Under CDC's National Comprehensive Cancer Control Program (NCCCP) 
Request for Applications DP5-1501, the Division of Cancer Prevention 
and Control (DCPC) funded six grantees to implement evidence-based and 
promising strategies to increase knowledge of cancer survivor needs, 
increase survivor knowledge of treatment and follow-up care, and 
increase provider knowledge of guidelines pertaining to treatment of 
cancer. Specifically, this initiative employs strategies that relate to 
increasing surveillance and community-

[[Page 52302]]

clinical linkages. Through this initiative, DCPC intends to help 
address the public health needs of cancer survivors. To facilitate 
evidence-informed policymaking and quality improvement of federal 
programs, CDC needs a comprehensive evaluation to characterize 
survivorship interventions and document outcomes.
    CDC seeks to request OMB approval to collect information needed for 
this evaluation. The proposed information collection will focus on how 
each grantee has expanded their knowledge of cancer survivor needs, 
increased utilization of surveillance data to inform program planning 
by providers and coalition members, and enhanced partnerships to 
facilitate and broaden program reach. CDC will also collect data on 
challenges encountered and addressed, factors that facilitated 
implementation, and lessons learned along the way. The requested 
information does not currently exist for organizations and entities 
working to improve cancer survivorship needs. With this data, CDC will 
gain critical insights for improving achieving immediate strategic 
efforts and goals to improve the public health needs of cancer 
survivors.
    CDC plans to collect information during two cycles of the program 
using a Web-based Grantee survey of NCCCP DP15-1501 grantee program 
directors and program managers, a Web-based Partner Survey of grantees' 
self-identified key partners (e.g., coalition members, providers, 
patient navigators), and semi-structured telephone interviews with 
NCCCP DP15-1501 grantee program directors and program managers. The 
data from the survey and semi-structured interviews will provide 
additional insight into program efforts.
    CDC is requesting OMB approval to conduct a Web-based Grantee 
survey using Survey Gizmo to a purposive sample of one program director 
and one program manager for each of the six grantee sites (12 
respondents total) and to conduct a Web-based Partner Survey of 10 
self-identified key partners in each of 6 grantees for a total of 60 
respondents. CDC will administer the Web-based surveys to the same 
respondents at two time points for a total estimated burden of 8 hours 
for the Web-based Grantee Survey and 40 hours for the Web-based Partner 
Survey.
    CDC will ask the respondents to provide information regarding the 
type of respondent; their use of surveillance data to inform 
survivorship interventions; communication, education, and training 
activities to support the implementation of survivorship interventions; 
partnership engagement; challenges and facilitators regarding the 
implementation of evidence-based cancer survivorship strategies; reach 
of cancer survivorship interventions; and respondent background 
information.
    CDC intends to also seek OMB approval to conduct semi-structured 
interviews by telephone with a purposive sample of one program director 
and one program manager for each of the six grantee sites (12 
respondents total). CDC will conduct the semi-structured interviews 
with the same respondents at two time points for a total estimated 
burden of 36 hours.
    CDC will ask the respondents to provide information on the 
following: (1) Administration of the Behavioral Risk Factor 
Surveillance System Cancer Survivorship Module; (2) communication, 
education, and training activities to support the implementation of 
cancer survivorship interventions; (3) community clinical linkage 
strategies to support cancer survivors, knowledge regarding best 
practices for survivorship care; partnership engagement; (4) 
dissemination of evidence-based survivorship interventions; and (5) 
recommendations for improving the implementation of evidence-based 
survivorship interventions.
    CDC will analyze the collected information and use in aggregate to 
inform future efforts to support cancer survivors and to initiate 
evidence-informed program decisions when rolling this initiative out to 
all NCCCP grantees. Without this data collection, CDC will not be able 
to provide tailored technical assistance to its grantees and 
communicate program efforts.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondent            Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
NCCCP Grantee Program Director  Web-based                     12               2           20/60               8
                                 Grantee survey.
                                Semi-structured               12               2            1.50              36
                                 telephone
                                 interview.
NCCCP Grantee Partner.........  Web-based                     60               2           20/60              40
                                 Partner survey.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............              84
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-24523 Filed 11-9-17; 8:45 am]
 BILLING CODE 4163-18-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice with comment period.
DatesCDC must receive written comments on or before January 12, 2018.
ContactTo request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected]
FR Citation82 FR 52301 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR